Recursion Pharmaceuticals (RXRX) investor relations material

Conference overview

• The event featured presentations from nearly 20 small and mid-cap companies, with a focus on industry innovation and financial performance.

• Analysts highlighted continued leadership and growth expectations for mid-cap companies in the second half of the year.

• Sessions included in-depth fireside chats and Q&A with company executives, providing insights into business models, strategy, and market positioning.

• The conference emphasized the breadth of BofA's coverage, spanning about 1,000 small and mid-cap U.S. companies.

• Attendees were encouraged to engage directly with analysts and company leaders for further research and session participation.

Key company insights and strategic updates

• Executives discussed the application of AI and technology to traditional industries, highlighting transformative impacts on efficiency and product offerings.

• Companies reported strong sequential growth in core business segments, with some achieving record contribution profits despite challenging macro conditions.

• Strategic focus shifted toward profitability and capital efficiency, with streamlined priorities and disciplined capital allocation.

• New product lines, such as home and auto lending, demonstrated significant improvement in contribution margins and are on track for profitability.

• Management addressed investor concerns about operating leverage, capital requirements, and the sustainability of growth rates.

Financial performance and guidance

• Companies highlighted robust growth in originations and fee-based revenue, supported by third-party funding and reduced reliance on balance sheet capital.

• Guidance reaffirmed a 35% compounded growth rate over the next few years, with a focus on maintaining strong margins and capital discipline.

• Executives explained the impact of macroeconomic factors, such as UMI, on guidance and performance, balancing strong execution with external headwinds.

• Operating expenses have grown due to intentional investments, but management expects the growth rate to slow, improving operating leverage.

• Share repurchases were prioritized over debt buybacks based on expected IRR, with a continued focus on maximizing capital efficiency.